Compare
Paychex Inc vs Gartner Inc vs Incyte Corp vs Genpact Ltd
| Latest fiscal year | Paychex Inc PAYX | Gartner Inc IT | Incyte Corp INCY | Genpact Ltd G |
|---|---|---|---|---|
| Year ended | 2026-05-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $6.51B | $6.50B | $5.14B | $5.08B |
| Revenue growth (YoY) | +16.9% | +3.7% | +21.2% | +6.6% |
| Gross margin | 74.3% (computed) | 68.8% | 92.8% (computed) | 36.0% |
| Operating margin | 38.6% | 15.8% | 29.5% | 14.8% |
| Net margin | 27.0% | 11.2% | 25.0% | 10.9% |
| Net income | $1.76B | $729.23M | $1.29B | $552.49M |
| EPS (Diluted) | $4.89 | $9.65 | $6.41 | $3.13 |
| Operating cash flow | $2.56B | $1.29B | $1.41B | $812.86M |
| Free cash flow | $2.32B | n/a | n/a | $734.65M |
| Cash & equivalents | $1.09B | $1.72B | $3.10B | $853.84M |
| Total assets | $16.17B | $8.09B | $6.96B | $5.84B |
| Total liabilities | $12.44B | $7.77B | $1.79B | $3.29B |
| Shareholders' equity | $3.74B | $319.91M | $5.17B | $2.55B |
| Return on year-end equity | 47.1% | 228.0% | 24.9% | 21.7% |
| Shares outstanding | 355.60M | n/a | 198.46M | 170.34M |
Revenue, most recent five fiscal years
| Fiscal year | Paychex Inc | Gartner Inc | Incyte Corp | Genpact Ltd |
|---|---|---|---|---|
| Latest | $6.51B Ended 2026-05-31 | $6.50B Ended 2025-12-31 | $5.14B Ended 2025-12-31 | $5.08B Ended 2025-12-31 |
| 1 year earlier | $5.57B Ended 2025-05-31 | $6.27B Ended 2024-12-31 | $4.24B Ended 2024-12-31 | $4.77B Ended 2024-12-31 |
| 2 years earlier | $5.28B Ended 2024-05-31 | $5.91B Ended 2023-12-31 | $3.70B Ended 2023-12-31 | $4.48B Ended 2023-12-31 |
| 3 years earlier | $5.01B Ended 2023-05-31 | $5.48B Ended 2022-12-31 | $3.39B Ended 2022-12-31 | $4.37B Ended 2022-12-31 |
| 4 years earlier | $4.61B Ended 2022-05-31 | $4.73B Ended 2021-12-31 | $2.99B Ended 2021-12-31 | $4.02B Ended 2021-12-31 |